CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
biliary stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02649712
NCT02649712N/ACompleted
CompareCT.gov

Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction

Xuzhou Central Hospital·interventional·Posted Jan 7, 2016·Updated Nov 20, 2018

In Brief

A clinical study evaluating biliary stent for Cholangiocarcinoma and 2 related conditions. Completed, enrolled 72 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the clinical effectiveness and long-term outcomes between patients with malignant hilar biliary obstruction who are treated by unilateral or bilateral stenting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCholangiocarcinoma, Gallbladder Carcinoma, Hepatocellular Carcinoma
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 7, 2016
Enrollment StartJan 20, 2016
Primary CompletionOct 31, 2018
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 10.5 years ago

Interventions

biliary stentdevice

Self-expandable biliary nitinol alloys stent